FI853560L - Foerfarande foer framstaellning av pregnanderivat. - Google Patents

Foerfarande foer framstaellning av pregnanderivat.

Info

Publication number
FI853560L
FI853560L FI853560A FI853560A FI853560L FI 853560 L FI853560 L FI 853560L FI 853560 A FI853560 A FI 853560A FI 853560 A FI853560 A FI 853560A FI 853560 L FI853560 L FI 853560L
Authority
FI
Finland
Prior art keywords
framework
hydrogen
framing processing
derivatives
iii
Prior art date
Application number
FI853560A
Other languages
English (en)
Finnish (fi)
Other versions
FI853560A0 (fi
Inventor
Helmut Hofmeister
Klaus Annen
Henry Laurent
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI853560A0 publication Critical patent/FI853560A0/fi
Publication of FI853560L publication Critical patent/FI853560L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Paper (AREA)
  • Sewage (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI853560A 1984-09-17 1985-09-17 Foerfarande foer framstaellning av pregnanderivat. FI853560L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843434448 DE3434448A1 (de) 1984-09-17 1984-09-17 Verfahren zur herstellung von pregnan-derivaten

Publications (2)

Publication Number Publication Date
FI853560A0 FI853560A0 (fi) 1985-09-17
FI853560L true FI853560L (fi) 1986-03-18

Family

ID=6245838

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853560A FI853560L (fi) 1984-09-17 1985-09-17 Foerfarande foer framstaellning av pregnanderivat.

Country Status (15)

Country Link
US (2) US4708823A (fr)
EP (1) EP0181442B1 (fr)
JP (1) JPH0710877B2 (fr)
AT (1) ATE44532T1 (fr)
CA (1) CA1260929A (fr)
CS (1) CS250695B2 (fr)
DD (1) DD238387A5 (fr)
DE (2) DE3434448A1 (fr)
DK (1) DK420985A (fr)
ES (1) ES8604987A1 (fr)
FI (1) FI853560L (fr)
GR (1) GR852241B (fr)
HU (1) HU194905B (fr)
PL (1) PL255391A1 (fr)
SU (1) SU1440351A3 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0523132A1 (fr) * 1990-03-27 1993-01-20 Schering Corporation PROCEDE DE DESHYDRATATION DE 9$g(a)-HYDROXY STEROIDES
AP141A (en) * 1990-04-25 1991-08-25 Richter Gedeon Vegyeszet Novel steroid doils.
WO1995030684A1 (fr) * 1994-05-09 1995-11-16 Pharmacia & Upjohn Company SYNTHESE DU 17β-CYANO-3-ETHOXY-17α-HYDROXY-6-METHYLANDROSTA-3,5,9(11)-TRIENE
JPH10191658A (ja) * 1996-01-09 1998-07-21 Nikon Corp 振動アクチュエータ
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
US6696592B2 (en) 2001-05-22 2004-02-24 Nicox-S.A. Methods of making 21-[4′-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof
CN103833814A (zh) * 2014-03-06 2014-06-04 浙江仙居君业药业有限公司 17羟基-孕甾-4-烯-3,20-二酮-21-醋酸酯的制备方法
CN105017364A (zh) * 2015-07-06 2015-11-04 湖南新合新生物医药有限公司 甲基泼尼松龙中间体及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067214A (en) * 1960-04-20 1962-12-04 Merck & Co Inc Haloethisterone compounds
DE2625306C2 (de) * 1976-06-02 1978-06-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Pregnan-Derivaten
HU185797B (en) * 1981-04-16 1985-03-28 Richter Gedeon Vegyeszet Process for producing 3-oxo-17-alpha-ethinyl-17beta-trifluoroacetoxy-gonane derivatives
EP0063368B1 (fr) * 1981-04-16 1984-07-25 Richter Gedeon Vegyeszeti Gyar R.T. Procédé de préparation de dérivés du pregn-4-ène-3,20-dione, ainsi que les dérivés du 17-alpha-éthynyl-17-bêta-trifluoroacétoxy-gon-4-ène-3-one et médicaments contenant ces derniers
HU183397B (en) * 1981-04-16 1984-04-28 Richter Gedeon Vegyeszet Process for preparing 17alpha-hydroxy-pregn-4-ene-3,20-dione derivatives
US4342702A (en) * 1981-05-18 1982-08-03 The Upjohn Company Metallated halogenated acetylene corticoid synthesis
DE3315324A1 (de) * 1983-04-25 1984-10-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 17(alpha)-(br oder j)-ethinyl-17ss-or-steroiden

Also Published As

Publication number Publication date
ATE44532T1 (de) 1989-07-15
EP0181442B1 (fr) 1989-07-12
HUT38951A (en) 1986-07-28
DK420985D0 (da) 1985-09-17
HU194905B (en) 1988-03-28
JPS61129197A (ja) 1986-06-17
PL255391A1 (en) 1986-07-15
ES8604987A1 (es) 1986-03-16
DK420985A (da) 1986-03-18
ES546995A0 (es) 1986-03-16
JPH0710877B2 (ja) 1995-02-08
GR852241B (fr) 1986-01-17
CS250695B2 (en) 1987-05-14
SU1440351A3 (ru) 1988-11-23
US4708823A (en) 1987-11-24
FI853560A0 (fi) 1985-09-17
US4956482A (en) 1990-09-11
DE3571441D1 (en) 1989-08-17
DE3434448A1 (de) 1986-03-27
DD238387A5 (de) 1986-08-20
EP0181442A1 (fr) 1986-05-21
CA1260929A (fr) 1989-09-26

Similar Documents

Publication Publication Date Title
ATE119905T1 (de) Makrolide antibiotika und verfahren zu deren herstellung.
ES8405795A1 (es) Procedimiento para la preparacion de derivados de b-carbolina
FI853560L (fi) Foerfarande foer framstaellning av pregnanderivat.
KR840005465A (ko) 19-티오-안드로스탄 유도체의 제조 방법
AU3406684A (en) Estrane and androstane derivatives
KR880011103A (ko) 5-아미노-4,6-디할로게노피리딘의 제조방법
KR850001766A (ko) 무라밀디펩타이드 활성 에스테르 유도체의 제조방법
IE790135L (en) Pregnene derivatives.
JPS6461496A (en) Production of 5'-ursodeoxycholic acid
FI875244A (fi) Foerfarande foer framstaellning av 6 ,9 -difluor-11 ,17 -dihydroxi-16--metyl-4-pregnen-3,20-dion och dess derivat.
FI841680A0 (fi) Nytt foerfarande foer framstaellning av 21-hydroxi-20-keto-delta 16-steroider och nya mellanprodukter som bildas i detta foerfarande.
IE37347B1 (en) Oxazolo (5,4-d) azepines
IE780933L (en) Pregnene derivatives
GR3003700T3 (fr)
KR830005262A (ko) 안드로스탄 카보리오에이트의 제조방법
GB991475A (en) Novel steroid compounds and processes for their production
ES8604951A1 (es) Procedimiento para la preparacion del o-sulfobenzoato imida del (+) 14, 15-dehidro- (3 , 16 )-eburnamenina-14-carboxilato de etilo
ES8206468A1 (es) Procedimiento de preparacion de derivados del acido 2-pirrol-acetico.
ES8405033A1 (es) Procedimiento para la obtencion de esteroides dihalogenados.
DK0496845T3 (da) Fremgangsmåde til fremstillig af 4-pregnen-3,20-dion og derivater deraf.
KR880005080A (ko) 피리딘 유도체의 제조방법
GB889311A (en) Androstenol derivatives
SE9300082D0 (sv) Novel colon- or ileum-specific steroid derivatives
GB1426353A (en) 15alpha,16alpha-methylene-5alpha-androstanes
JPS55167299A (en) 25-hydroperoxy-24-oxocholestane derivative

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT